~~<i id='8D6391ABC6'><strike id='8D6391ABC6'><tt id='8D6391ABC6'><pre id='8D6391ABC6'></pre></tt></strike></i>~~

Home» Wikipedia» explore

explore

author：focus 2025-10-06 06:14:17 Page View：5548

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships
Next article： As demand for Covid shots wanes, Moderna seeks its next success

knowledge

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

(APIllustration/PeterHamlin)TheAssociatedPressWhenOpenTableCEODebbySoojoinedtherestaurantreservation

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

RAMALLAH,WestBank--IsraelisecurityforcesonTuesdaydemolishedtheWestBankhomeofaPalestinianmanaccusedof